EFA 14th Conference: the Case of Reimbursement and Health Technology Assessment

First session: Reimbursement

Involvement of patient organisations in reimbursement decision:
Lithuania L. Buzermaniene
Portugal L.M. Vieira de Araujo
France C. Rolland
Bulgaria N. Grigorova
Sweden P.-A. Wecksell
Switzerland G. Shäppi

How is reimbursement of pharmaceutical products achieved? M. Caesar, Germany
Reimbursement, HTA and Regulatory Agencies modalities of increased co-operation A. van Halteren, the Netherlands

Reimbursement practice and development in selected countries:
UK J. Versnel
Germany A. Rüther
Italy F. Gianfrate
France M. Brunn
Spain J. Brana Pino

Second session: Involvement of Patients

Are people with allergy, asthma and COPD involved in decisions on their treatment and are their associations involved in drug regulatory process? J. Versnel, UK
EFA Book on COPD in Europe S. Palkonen and A. Fink-Wagner, EFA

Third session: Health Technology Assessment (HTA)

Introduction and good practice in involving patients S. Palkonen, L. Souchet, M. Salapatas, EFA